Evaluation of the use of antibiotics in a health area.

Evaluation of the use of antibiotics in a health area.

Main Article Content

Juan Carlos García de Paredes Esteban
María del Rocío Castaño Lara
Cristina Mora Herrera

Abstract

The use of antibiotics is one of the main tools for the therapeutic management of most infections of bacterial origin. It is excessive and unnecessary use can cause damage to both public and individual health. The work that we present part of the research carried out in a health area with a population of about 84 thousand inhabitants. The main objective was to analyze the use of antibiotic drugs in our health area, global consumption and the consumption according to the type of antibiotic. Secondary objective was to compare the results obtained with the results reflected at the national level. Data were obtained through an electronic medical prescription billing software and the dose per inhabitant per day (DHD) measurement variable was used. The results showed that in our health area a lower use of antibiotics is observed in comparison with the data available nationwide, average consumption of antibiotics in Spain in the outpatient setting in 2017 was 16.13 DHD versus 15.22 DHD in our area

References

Agencia Española de Medicamentos y Productos Sanitarios (2015). Plan estratégico y de acción
para reducir el riesgo de selección y diseminación de la resistencia a los antibióticos.
Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad.

Agencia Española de Medicamentos y Productos Sanitarios (2017). Indicadores de uso de
antibióticos en Atención Primaria. Madrid: Ministerio de Sanidad, Servicios Sociales e
Igualdad.

Baos, V., González, A.B., Fadini, E.D., Villena, A.E., Riera, T.E., Fernández, J.I., ... y Rodríguez,
A.M.Q. (2006). Documento de consenso sobre la utilización de antibióticos en atención
primaria. Atención Primaria, 38(3), 174-177.

Dellit, T.H., Owens, R.C., McGowan, J.E., Gerding, D.N., Weinstein, R.A., Burke, J.P., ... y
Brennan, P.J. (2007). Infectious Diseases Society of America and the Society for
Healthcare Epidemiology of America guidelines for developing an institutional program
to enhance antimicrobial stewardship. Clinical Infectious Diseases, 44(2), 159-177.

European Centre for Disease Control, ECDC (2009). The Bacterial Challenge: Time to React a
Call to Narrow the Gap between Multidrug-Resistant Bacteria in the EU and
Development of New Antibacterial Agents. Solna: ECDC y EMEA Joint Press Release.

European Centre for Disease Prevention and Control, ECDC (2013). Point prevalence survey of
healthcareassociated infections and antimicrobial use in European acute care hospitals.
Estocolmo: ECDC.

Larrea, V.P., Penella, A.M., y Mir, I.M. (2003). Reflexiones sobre la utilización de antibióticos en
atención primaria. Atención Primaria, 32(1), 42-47.

Llor, C., y Hernandez, S. (2010). Infectious disease in primary care: 1-year prospective
study. Enfermedades Infecciosas y Microbiología Clínica, 28(4), 222-226.

Machado, J.E., y González, D.M. (2009). Dispensing antibiotics to outpatients in a Colombian
population. Revista de Salud Pública, 11(5), 734-744.

Martínez, L., y Calvo, J. (2010). Desarrollo de las resistencias a los antibióticos: causas,
consecuencias y su importancia para la salud pública. Enfermedades Infecciosas y
Microbiología Clínica, 28, 4-9.

OECD (2015). Health at a Glance 2015: OECD Indicators. Paris: OECD Publishing.
Organización Mundial de la Salud, OMS (2018). Guidelines for ATC classification and DDD
assignment 2019. Ginebra: OMS.

Plan Nacional Resistencia Antibióticos, PRAN (2018). Consumos Antibióticos Sector
Comunitario. España: Agencia Española de Medicamentos y Productos Sanitarios.
Real Decreto 1718/2010 sobre receta médica y órdenes de dispensación (2010). Boletín Oficial del
Estado Nº17, 01 de diciembre de 2016, España.

Sánchez, M.L., Eiros, J. M., Arbizu, R., y Rozada, S. (2018). Vigilancia del consumo de
antibióticos en España: la importancia del indicador DHD. Atención Primaria, 50(3),
199-200.